The digital services and consulting company announced the launch of Infosys Topaz for SAP S/4HANA Cloud, an AI-first suite. This offering will help enterprises harness the power of AI and Gen AI in their SAP S/4HANA Cloud transformation journey.
The Board will meet on May 3 to consider raising equity during FY26 through follow-on public offer (FPO), rights issue, qualified institutional placement (QIP), or any other mode. The Board will also consider the March quarter and FY25 earnings on the same day.
Shareholders have approved the re-appointment of Juby Chandy as Whole-time Director & CFO of the company for a period of two years, effective April 1.
Nitin Kumar Yadav, IAS, Joint Secretary, Department of Commerce, has been appointed as Chairman & Managing Director (CMD) (additional charge) on the Board of the company for a period of one year, effective April 29.
The Board will consider the issue of bonus shares on May 2.
The company has received approval from the Real Estate Regulatory Authority (RERA) and has launched the residential project ‘The Prestige City – Indirapuram’ in the National Capital Region (NCR). The gross development value (GDV) of the project is estimated at over Rs 9,000 crore.
The company’s subsidiary, Strides Pharma Inc, in the US has acquired four approved ANDAs for the US market from Nostrum Laboratories Inc., USA. The portfolio comprises liquids and immediate-release solid orals in therapeutic segments that treat urinary tract infections (UTIs), pain management, allergy symptoms, attention deficit disorder (ADD/ADHD), and narcolepsy. The cumulative market size for the acquired portfolio is $57 million, as per IQVIA 2025 data.
Sumant Kathpalia has resigned as Managing Director & CEO, effective April 29. The Board has sought approval from the Reserve Bank of India (RBI) to constitute a Committee of Executives to discharge the duties, roles, and responsibilities of the CEO for an interim period until a permanent CEO is appointed. In his resignation letter, Kathpalia stated that he was stepping down in relation to the ongoing derivatives discussion and undertook moral responsibility for various acts of commission/omission.
Profit jumps 14.1% to Rs 2,416.6 crore Vs Rs 2,118.5 crore
Revenue increases 14.2% to Rs 36,595.4 crore Vs Rs 32,040.8 crore
Bharat Petroleum Corporation (BPCL) Q4 (Standalone QoQ)
Profit sinks 30.9% to Rs 3,214.1 crore Vs Rs 4,649.2 crore
Revenue declines 1.7% to Rs 1,11,179 crore Vs Rs 1,13,136 crore
Board recommends final dividend of Rs 5 per share
Profit tanks 61.6% to Rs 123.5 crore Vs Rs 321.7 crore
Net interest income rises 0.9% to Rs 596.9 crore Vs Rs 591.8 crore
Tax credit at Rs 3.64 crore Vs tax credit at Rs 155.2 crore
Gross NPA falls to 2.71% Vs 2.80% (QoQ)
Net NPA flat at 0.94% (QoQ)
Profit drops 18% to Rs 124 crore Vs Rs 151.3 crore
Revenue declines 3.2% to Rs 316.9 crore Vs Rs 327.5 crore
Board recommends final dividend of Rs 26 per share, special dividend of Rs 22 per share
Profit plunges 99.6% to Rs 0.51 crore Vs Rs 142.3 crore
Net premium earned grows 11.9% to Rs 3,798.3 crore Vs Rs 3,395.3 crore
Underwriting loss widens to Rs 275.2 crore Vs loss of Rs 91.8 crore
Operating loss stands at Rs 86.9 crore Vs operating profit of Rs 90 core
Vikasdhan - Grow your Dhan with Vikasdhan
Disclaimer- not an investment advice, only for educational purpose. To read complete disclaimer, click on the link https://www.vikasdhan.com/disclaimer